iScience (May 2025)

Immune imprinting and antibody profiles to SARS-CoV-2 in urban and rural Ghana

  • Martin Montiel-Ruiz,
  • Elvis S. Lomotey,
  • Elizabeth Obeng-Aboagye,
  • Isaac Quaye,
  • Daniel A. Odumang,
  • Florence B. Amakye,
  • Bernard A. Logonia,
  • Salomé Lochmann,
  • Joseph A. Hayford,
  • Dickson K. Osabutey,
  • Angelica Daakyire,
  • Christopher Dorcoo,
  • Edward Dumashie,
  • Joseph Quartey,
  • Dorothy Yeboah-Manu,
  • George B. Sigal,
  • Scott D. Boyd,
  • Irene Owusu Donkor,
  • Katharina Röltgen

DOI
https://doi.org/10.1016/j.isci.2025.112511
Journal volume & issue
Vol. 28, no. 5
p. 112511

Abstract

Read online

Summary: Infections with SARS-CoV-2 and the development of immunity to the virus and its antigenic variants have been unevenly documented globally, with African populations particularly understudied. As SARS-CoV-2 transitions toward being an endemic pathogen, a more nuanced understanding of immune protection in diverse populations is required. In 2023, we conducted a cross-sectional study of 1,000 Ghanaian residents to assess SARS-CoV-2 prevalence and antibody correlates of immunity against SARS-CoV-2 variants. We found an active SARS-CoV-2 infection rate of 1.3% and a 57% vaccination rate. We observed anti-SARS-CoV-2 Spike plasma antibody sero-positivity of 98.7%, with urban compared to rural residents having higher anti-SARS-CoV-2 plasma and saliva antibody concentrations. Vaccinated and urban individuals exhibited significantly greater Spike-pseudotyped virus neutralization than nonvaccinated and rural individuals. Notably, plasma antibodies preferentially bound Wuhan-Hu-1 over Omicron Spike variants. Our findings indicate significant prior and ongoing SARS-CoV-2 transmission as well as immunological imprinting by Wuhan-Hu-1-like SARS-CoV-2 in Ghana.

Keywords